Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1980 1
1988 1
1990 1
1991 2
1992 2
1994 2
1995 1
1996 1
1999 1
2000 2
2001 7
2002 5
2003 8
2004 9
2005 6
2006 1
2007 9
2008 6
2009 6
2010 8
2011 7
2012 2
2013 6
2014 6
2015 1
2016 1
2017 1
2019 3
2020 6
2021 4
2022 2
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Hemophagocytosis in autoimmune disease.
Sekigawa I, Suzuki J, Nawata M, Ikeda K, Koike M, Iida N, Hashimoto H, Oshimi K. Sekigawa I, et al. Among authors: nawata m. Clin Exp Rheumatol. 2001 May-Jun;19(3):333-8. Clin Exp Rheumatol. 2001. PMID: 11407091 Review.
MR visualization of the insula.
Nawata M. Nawata M. Magn Reson Med Sci. 2003 Oct 1;2(3):141-4. doi: 10.2463/mrms.2.141. Magn Reson Med Sci. 2003. PMID: 16222105 Free article.
Effects of dialysis on the pharmacokinetics of salazosulfapyridine.
Inami Y, Yamaji K, Sato M, Gohda T, Io H, Nawata M, Hamada C, Takasaki Y, Tomino Y. Inami Y, et al. Among authors: nawata m. Rheumatol Int. 2013 Feb;33(2):535-9. doi: 10.1007/s00296-011-2179-1. Epub 2011 Nov 12. Rheumatol Int. 2013. PMID: 22080212
Ultrasound efficacy of targeted-synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: a multicenter prospective cohort study in Japan.
Endo Y, Kawashiri SY, Nishino A, Michitsuji T, Tomokawa T, Nishihata S, Okamoto M, Tsuji Y, Tsuji S, Shimizu T, Sumiyoshi R, Igawa T, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Yoshitama T, Eiraku N, Matsuoka N, Okada A, Fujikawa K, Otsubo H, Takaoka H, Hamada H, Tsuru T, Nawata M, Arinobu Y, Hidaka T, Tada Y, Kawakami A. Endo Y, et al. Among authors: nawata m. Scand J Rheumatol. 2022 Jul;51(4):259-267. doi: 10.1080/03009742.2021.1927389. Epub 2021 Sep 2. Scand J Rheumatol. 2022. PMID: 34474646
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.
Sonomoto K, Nakayamada S, Fujino Y, Miyata H, Kubo S, Fujita Y, Inoue Y, Matsunaga S, Iwata S, Hanami K, Todoroki Y, Yoshinari-Korekoda H, Kawabe A, Yamaguchi A, Ueno M, Satoh-Kanda Y, Kanda R, Funada M, Ohkubo N, Kusaka K, Kosaka S, Nagayasu A, Fukuyo S, Nawata M, Miyazaki Y, Tokunaga M, Tanaka K, Okada Y, Tanaka Y. Sonomoto K, et al. Among authors: nawata m. Rheumatology (Oxford). 2023 Nov 2:kead579. doi: 10.1093/rheumatology/kead579. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37934120
Trabecular minimodeling in human iliac bone.
Kobayashi S, Takahashi HE, Ito A, Saito N, Nawata M, Horiuchi H, Ohta H, Ito A, Iorio R, Yamamoto N, Takaoka K. Kobayashi S, et al. Among authors: nawata m. Bone. 2003 Feb;32(2):163-9. doi: 10.1016/s8756-3282(02)00947-x. Bone. 2003. PMID: 12633788
Efficacy and safety of reducing duration of infliximab infusion.
Fukuyo S, Saito K, Yamaoka K, Sawamukai N, Hirata S, Nawata M, Iwata S, Tanaka Y. Fukuyo S, et al. Among authors: nawata m. Mod Rheumatol. 2014 Mar;24(2):275-80. doi: 10.3109/14397595.2013.843747. Epub 2013 Oct 11. Mod Rheumatol. 2014. PMID: 24251990
112 results